The SF-36 as a health status measure for epilepsy: A psychometric assessment

Quality of Life Research

Volumn 8, Issue 4, 1999, Pages 351-364

  Jacoby, Ann ^a   Baker, Gus A ^b   Steen, Nick ^c   Buck, Deborah ^c  

^a Centre for Health Services Research   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Data quality; Epilepsy; Reliability; SF 36 health survey; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DISCRIMINANT ANALYSIS; EPILEPSY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; RELIABILITY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; EPILEPSY; EUROPE; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 0032776088     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008902728574     Document Type: Article

References (31)

1. 1. McHorney CA, Ware JE, Lu R, Donald Sherbourne C. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care 1994; 32: 40-66.
2. 2. Wagner AK, Keller SD, Kosinski M, et al. Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life. Quality of Life Research 1995; 4: 115-134.
3. 3. Malmgren K, Sullivan M, Ekstedt G, Kullberg G, Kumlien E. Health-related quality of life after epilepsy surgery: a Swedish multicenter study. Epilepsia 1997; 38: 830-838.
4. 4. Vickrey BG, Hays RD, Graber J, Rausch R, Engel J, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Medical Care 1992; 30(4): 299-319.
5. 5. Devinsky O, Vickrey BG, Cramer J, et al. Development of the quality of life in epilepsy inventory. Epilepsia 1995; 36: 1089-1104.
6. 6. Jacoby A, Johnson AL, Chadwick DW. Psychosocial outcomes of antiepileptic drug discontinuation. Epilepsia 1992; 33(6): 1123-1131.
7. 7. Bladin PF. Psychosocial difficulties and outcome after temporal lobectomy. Epilepsia 1992; 33: 898-907.
8. 8. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997; 38: 859-880.
9. 9. Mignot G. Drug trials in epilepsy. British Medical Journal 1997; 313: 1158.
10. 10. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997; 38: 439-444.
11. 11. Jacoby A, Baker GA, Smith DF, Dewey M, Chadwick DW. Measuring the impact of epilepsy: the development of a novel scale. Epilepsy Research 1993; 16: 83-88.
12. 12. Jacoby A. Felt versus enacted stigma: a concept revisited. Social Science and Medicine 1994; 38: 269-274.
13. 13. Baker GA, Jacoby A, Francis P, Chadwick DW. The Liverpool adverse drug events profile. Epilepsia 1995; 36: S59.
14. 14. Aaronson NK, Acquadro C, Alonso J. International Quality of Life Assessment (IQOLA) Project. Quality of Life Research 1992; 1: 349-351.
15. 15. Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. British Medical Journal 1992; 305: 160-164.
16. 16. Jenkinson C, Coulter A, Wright L. Short form 36 (SF 36) health survey questionnaire: normative data for adults of working age. British Medical Journal 1993; 306: 1437-1440.
17. 17. Meadows K, Bentzen N, Touw-Otten F. Cross-cultural issues: an outline of the important principles in establishing cross-cultural validity in health outcome measurement. In: Hutchinson A, Bentzen N, Konig-Zahn C, eds. Cross cultural health outcome assessment: a user's guide. Groningen, The Netherlands: European Research Group on Health Outcomes (ERGHO), 1997.
18. 18. Cartwright A. Health surveys in practice and in potential. London: King's Fund, 1983.
19. 19. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992; 30(6): 473-483.
20. 20. Nerenz DR, Repasky DP, Whitehouse FW, et al. Ongoing assessment of health status in patients with diabetes mellitus. Medical Care 1992; 30: 112-124.
21. 21. Garratt AM, Ruta DA, Abdalla MI, et al. The SF-36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? British Medical Journal 1993; 306: 1440-1444.
22. 22. Garratt AM, Macdonald LM, Ruta DA, Russell IT, Buckingham JK, Krukowski ZH. Towards measurement of outcome for patients with varicose veins. Quality in Health Care 1993; 2: 5-10.
23. 23. SPSS Inc. SPSS Users Manual. Chicago: SPSS Inc, 1990.
24. 24. Kline P. A handbook of test construction. London: Methuen, 1986.
25. 25. Nunally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill Inc, 1994.
26. 26. Chadwick D, Epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 1994; 57: 264-277.
27. 27. Jacoby A, Baker GA, Steen N, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study. Epilepsia 1996; 37: 148-161.
28. 28. Buck D, Jacoby A, Baker GA, Ley P. Cross-cultural differences in HRQOL of people with epilepsy: findings from a European study. Quality of life Research 1999; (submitted).
29. 29. Stewart AL, Hays RD, Ware JE. The MOS Short-Form General Health Survey: reliability and validity in a patient population. Medical Care 1988; 26: 724-724.
30. 30. Cox DR, Fitzpatrick R, Fletcher AE, Gore SM. Spiegelhalter DJ, Jones DR. Quality of life assessment: can we keep it simple? Journal of the Royal Statistical Society 1992; 155(3): 353-393.
31. 31. Guyatt G, Feeny DH, Patrick DL. Measuring health-related quality of life. Annals of Internal Medicine 1993; 118: 622-629.